US Stock MarketDetailed Quotes

Design Therapeutics (DSGN)

Watchlist
  • 9.360
  • -0.440-4.49%
Close Jan 15 16:00 ET
533.18MMarket Cap-7.87P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Design Therapeutics (DSGN) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.93%-11.16M
-28.25%-14.44M
-34.97%-16.79M
26.39%-43.11M
22.96%-9.86M
34.32%-9.55M
18.43%-11.26M
28.61%-12.44M
-14.11%-58.56M
15.19%-12.8M
Net income from continuing operations
-30.36%-17M
-61.82%-19.08M
-59.52%-17.72M
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
Depreciation and amortization
1.31%155K
0.66%152K
11.19%159K
10.99%596K
7.97%149K
11.68%153K
13.53%151K
10.85%143K
32.27%537K
11.29%138K
Other non cash items
-800.00%-7K
10,525.00%425K
-200.00%-4K
-81.82%6K
-160.00%-3K
-87.50%1K
-60.00%4K
-60.00%4K
-48.44%33K
-54.55%5K
Change In working capital
70.78%2.86M
173.74%994K
41.79%-1.71M
-236.40%-993K
181.13%1.61M
519.25%1.68M
-136.75%-1.35M
-430.56%-2.93M
-63.45%728K
-3,053.97%-1.99M
-Change in prepaid assets
-30.45%459K
171.97%452K
-242.34%-1.41M
-88.55%226K
-26.49%605K
203.29%660K
-205.02%-628K
-134.48%-411K
158.18%1.97M
274.73%823K
-Change in payables and accrued expense
136.48%2.41M
175.28%542K
88.07%-301K
2.17%-1.22M
135.84%1.01M
325.52%1.02M
-123.45%-720K
-44.58%-2.52M
-123.14%-1.25M
-788.73%-2.81M
Cash from discontinued investing activities
Operating cash flow
-16.93%-11.16M
-28.25%-14.44M
-34.97%-16.79M
26.39%-43.11M
22.96%-9.86M
34.32%-9.55M
18.43%-11.26M
28.61%-12.44M
-14.11%-58.56M
15.19%-12.8M
Investing cash flow
Cash flow from continuing investing activities
211.74%6.51M
-26.40%20.12M
-61.83%7.87M
-16.33%43.96M
-67.02%1.83M
-138.16%-5.83M
128.12%27.33M
4.47%20.62M
123.77%52.54M
626.04%5.56M
Net PPE purchase and sale
--0
45.96%-87K
63.08%-72K
-32.81%-340K
--0
130.19%16K
-80.90%-161K
-124.14%-195K
72.11%-256K
90.63%-27K
Net investment purchase and sale
211.43%6.51M
-26.52%20.2M
-61.84%7.94M
-16.10%44.3M
-67.18%1.83M
-138.14%-5.84M
127.77%27.49M
5.00%20.81M
123.98%52.79M
826.82%5.58M
Cash from discontinued investing activities
Investing cash flow
211.74%6.51M
-26.40%20.12M
-61.83%7.87M
-16.33%43.96M
-67.02%1.83M
-138.16%-5.83M
128.12%27.33M
4.47%20.62M
123.77%52.54M
626.04%5.56M
Financing cash flow
Cash flow from continuing financing activities
3,600.00%37K
57.64%361K
15.00%23K
-29.14%513K
-47.50%263K
-92.31%1K
9.05%229K
20K
208.09%724K
285.38%501K
Proceeds from stock option exercised by employees
3,600.00%37K
57.64%361K
15.00%23K
-29.14%513K
-47.50%263K
-92.31%1K
9.05%229K
--20K
9.37%724K
285.38%501K
Cash from discontinued financing activities
Financing cash flow
3,600.00%37K
57.64%361K
15.00%23K
-29.14%513K
-47.50%263K
-92.31%1K
9.05%229K
--20K
208.09%724K
285.38%501K
Net cash flow
Beginning cash position
-56.89%19.7M
-53.51%13.67M
6.43%22.56M
-20.00%21.2M
8.54%30.33M
68.03%45.7M
2.04%29.4M
-20.00%21.2M
-91.12%26.5M
-34.28%27.94M
Current changes in cash
69.98%-4.62M
-62.97%6.04M
-208.53%-8.9M
125.72%1.36M
-15.17%-7.77M
-2,163.22%-15.37M
1,111.29%16.3M
255.00%8.2M
98.05%-5.3M
57.91%-6.74M
End cash Position
-50.25%15.09M
-56.89%19.7M
-53.51%13.67M
6.43%22.56M
6.43%22.56M
8.54%30.33M
68.03%45.7M
2.04%29.4M
-20.00%21.2M
-20.00%21.2M
Free cash flow
-17.12%-11.16M
-27.20%-14.53M
-33.46%-16.86M
26.13%-43.45M
23.12%-9.86M
34.67%-9.53M
17.79%-11.42M
27.85%-12.63M
-12.60%-58.82M
16.61%-12.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.93%-11.16M-28.25%-14.44M-34.97%-16.79M26.39%-43.11M22.96%-9.86M34.32%-9.55M18.43%-11.26M28.61%-12.44M-14.11%-58.56M15.19%-12.8M
Net income from continuing operations -30.36%-17M-61.82%-19.08M-59.52%-17.72M25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M
Depreciation and amortization 1.31%155K0.66%152K11.19%159K10.99%596K7.97%149K11.68%153K13.53%151K10.85%143K32.27%537K11.29%138K
Other non cash items -800.00%-7K10,525.00%425K-200.00%-4K-81.82%6K-160.00%-3K-87.50%1K-60.00%4K-60.00%4K-48.44%33K-54.55%5K
Change In working capital 70.78%2.86M173.74%994K41.79%-1.71M-236.40%-993K181.13%1.61M519.25%1.68M-136.75%-1.35M-430.56%-2.93M-63.45%728K-3,053.97%-1.99M
-Change in prepaid assets -30.45%459K171.97%452K-242.34%-1.41M-88.55%226K-26.49%605K203.29%660K-205.02%-628K-134.48%-411K158.18%1.97M274.73%823K
-Change in payables and accrued expense 136.48%2.41M175.28%542K88.07%-301K2.17%-1.22M135.84%1.01M325.52%1.02M-123.45%-720K-44.58%-2.52M-123.14%-1.25M-788.73%-2.81M
Cash from discontinued investing activities
Operating cash flow -16.93%-11.16M-28.25%-14.44M-34.97%-16.79M26.39%-43.11M22.96%-9.86M34.32%-9.55M18.43%-11.26M28.61%-12.44M-14.11%-58.56M15.19%-12.8M
Investing cash flow
Cash flow from continuing investing activities 211.74%6.51M-26.40%20.12M-61.83%7.87M-16.33%43.96M-67.02%1.83M-138.16%-5.83M128.12%27.33M4.47%20.62M123.77%52.54M626.04%5.56M
Net PPE purchase and sale --045.96%-87K63.08%-72K-32.81%-340K--0130.19%16K-80.90%-161K-124.14%-195K72.11%-256K90.63%-27K
Net investment purchase and sale 211.43%6.51M-26.52%20.2M-61.84%7.94M-16.10%44.3M-67.18%1.83M-138.14%-5.84M127.77%27.49M5.00%20.81M123.98%52.79M826.82%5.58M
Cash from discontinued investing activities
Investing cash flow 211.74%6.51M-26.40%20.12M-61.83%7.87M-16.33%43.96M-67.02%1.83M-138.16%-5.83M128.12%27.33M4.47%20.62M123.77%52.54M626.04%5.56M
Financing cash flow
Cash flow from continuing financing activities 3,600.00%37K57.64%361K15.00%23K-29.14%513K-47.50%263K-92.31%1K9.05%229K20K208.09%724K285.38%501K
Proceeds from stock option exercised by employees 3,600.00%37K57.64%361K15.00%23K-29.14%513K-47.50%263K-92.31%1K9.05%229K--20K9.37%724K285.38%501K
Cash from discontinued financing activities
Financing cash flow 3,600.00%37K57.64%361K15.00%23K-29.14%513K-47.50%263K-92.31%1K9.05%229K--20K208.09%724K285.38%501K
Net cash flow
Beginning cash position -56.89%19.7M-53.51%13.67M6.43%22.56M-20.00%21.2M8.54%30.33M68.03%45.7M2.04%29.4M-20.00%21.2M-91.12%26.5M-34.28%27.94M
Current changes in cash 69.98%-4.62M-62.97%6.04M-208.53%-8.9M125.72%1.36M-15.17%-7.77M-2,163.22%-15.37M1,111.29%16.3M255.00%8.2M98.05%-5.3M57.91%-6.74M
End cash Position -50.25%15.09M-56.89%19.7M-53.51%13.67M6.43%22.56M6.43%22.56M8.54%30.33M68.03%45.7M2.04%29.4M-20.00%21.2M-20.00%21.2M
Free cash flow -17.12%-11.16M-27.20%-14.53M-33.46%-16.86M26.13%-43.45M23.12%-9.86M34.67%-9.53M17.79%-11.42M27.85%-12.63M-12.60%-58.82M16.61%-12.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -